CN102600313B - Medicinal composition for treating polycystic ovary syndrome - Google Patents
Medicinal composition for treating polycystic ovary syndrome Download PDFInfo
- Publication number
- CN102600313B CN102600313B CN201210108674.4A CN201210108674A CN102600313B CN 102600313 B CN102600313 B CN 102600313B CN 201210108674 A CN201210108674 A CN 201210108674A CN 102600313 B CN102600313 B CN 102600313B
- Authority
- CN
- China
- Prior art keywords
- grams
- polycystic ovary
- ovary syndrome
- medicinal composition
- stir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicinal composition for treating polycystic ovary syndrome. The medicinal composition is characterized by comprising the following medicinal components by weight: 8g of processed pangolin, 12g of eucommia bark, 12g of Chinese dodder seed, 8g of chicken's gizzard-membrane, 20g of processed rehmannia, 12g of epimedium herb, and 3g of safflower. The medicinal composition for treating the polycystic ovary syndrome has the advantages of high cure rate, low raw material price and no harm to patient after healing.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of infertility, be specially a kind of pharmaceutical composition for the treatment of polycystic ovary disease.
Background technology
Due to the impact of each side factor congenital or posteriority, infertility is perplexing a plurality of families always, is also the field that medical circle is constantly deepened research all the time.
Polycystic ovary syndrome (polycystic ovarian syndrome) is a kind of reproductive function obstacle and abnormal carbohydrate metabolism the endocrine regulation syndrome deposited.Because ovulation failure causes infertile, it is the main clinical manifestation of polycystic ovarian syndrome.The definite cause of disease of polycystic ovary syndrome is not quite clear, think that at present ovary produces too much androgen, and androgenic excessive generation is due to the synergistic result of multiple hormonal system dysfunction in body.
Therapeutic Method for polycystic ovary syndrome is divided into doctor trained in Western medicine and two kinds of modes of the traditional Chinese medical science at present: the Therapeutic Method of doctor trained in Western medicine mostly is operation and instrument treatment, large to person damaging, and healing is not thorough, and with high costs; The existing traditional Chinese medical science is also to adopt Drug therapy, but DeGrain, and complicated operation.
Therefore, provide a kind of cure rate high, and after curing to the person medicine without the novel therapeutic polycystic ovary syndrome of injury, be a urgent problem.
Summary of the invention
In order to overcome above-mentioned deficiency of the prior art, the invention provides a kind of cure rate high, and after curing to patient body the pharmaceutical composition without the novel therapeutic polycystic ovary syndrome of injury.
The object of the present invention is achieved like this:
A pharmaceutical composition for the treatment of polycystic ovary syndrome, is characterized in that, is formed: stir-baked SQUAMA MANITIS, the Cortex Eucommiae, Semen Cuscutae, Endothelium Corneum Gigeriae Galli, Radix Rehmanniae Preparata, Herba Epimedii, Stigma Croci by following medicine components proportioning;
Described component quality proportioning is: 8 grams of stir-baked SQUAMA MANITISs, 12 grams of the Cortexs Eucommiae, 12 grams of Semen Cuscutae, 8 grams of Endothelium Corneum Gigeriae Galli, 20 grams of Radix Rehmanniae Preparata, 12 grams of Herba Epimedii, 3 grams of Stigma Crocis.
Positive helpful effect: medicine composite for curing polycystic ovary syndrome cure rate provided by the invention is high, and raw material is cheap, and after curing to patient without injury.
the specific embodiment:
Below in conjunction with the specific embodiment, the present invention is further illustrated:
A pharmaceutical composition for the treatment of polycystic ovary syndrome, is characterized in that, is formed: stir-baked SQUAMA MANITIS, the Cortex Eucommiae, Semen Cuscutae, Endothelium Corneum Gigeriae Galli, Radix Rehmanniae Preparata, Herba Epimedii, Stigma Croci by following medicine components proportioning;
Described component quality proportioning is: 8 grams of stir-baked SQUAMA MANITISs, 12 grams of the Cortexs Eucommiae, 12 grams of Semen Cuscutae, 8 grams of Endothelium Corneum Gigeriae Galli, 20 grams of Radix Rehmanniae Preparata, 12 grams of Herba Epimedii, 3 grams of Stigma Crocis.
Pharmacology analysis:
Stir-baked SQUAMA MANITIS
Stir-baked SQUAMA MANITIS nature and flavor are salty, be slightly cold: return liver, kidney channel.Main effect is promoting blood circulation to restore menstrual flow, detumescence and apocenosis.
Stir-baked SQUAMA MANITIS is good at walking to alter, and property specially row is loose, and the power of promoting blood circulation to remove blood stasis is stronger, can tonneau meridians and through sick institute.
The Cortex Eucommiae
Cortex Eucommiae nature and flavor are sweet, warm: return liver, kidney channel.Main effect is invigorating the liver and kidney, bone and muscle strengthening, antiabortive.
The Cortex Eucommiae is good at invigorating the liver and kidney and leak-stopping is antiabortive.Cortex Eucommiae decoct and alcohol extract can resist the uteri excitation effect that pituitrin and acetylcholine cause, make the recover of uterus of contraction state normal.
Semen Cuscutae
Semen Cuscutae nature and flavor are pungent, sweet, flat; Return liver,spleen,kidney warp.Main effect is that YANG invigorating tonifying YIN, warming the spleen nourish blood.
Semen Cuscutae cures mainly kidney Qi deficiency, dysfunction of the kidney in storing essence, the more than and ovarian disease of women's leukorrhagia, metrorrhagia.Can strengthen the cardiac contractile force of in vitro white mice, and isolated uterine is had to excitation.
Endothelium Corneum Gigeriae Galli
Endothelium Corneum Gigeriae Galli nature and flavor are sweet, flat; Return spleen, stomach, small intestinal, urinary bladder channel.Main effect is that activating the spleen helps digestion, controlling nocturnal emission with astringent drugs is only lost.
Radix Rehmanniae Preparata
Radix Rehmanniae Preparata nature and flavor are sweet, tepor; Return liver, kidney channel.Main effect is nourishing the blood and yin, vital essence replenishing and marrow benifiting.
Radix Rehmanniae Preparata cures mainly blood deficiency disease; Menoxenia, disintegration; Hepatic and renal YIN deficiency disease.Married woman be take blood as this, blood take fill smooth as suitable.Menoxenia is often because of due to blood deficiency and blood stasis.Radix Rehmanniae Preparata sweet in the mouth tepor, matter is grown quiet keeping and the kind yin nourishing of enriching blood, therefore can be used for the diseases such as menoxenia, blood deficiency is especially suitable without stagnant person.
Herba Epimedii
Herba Epimedii nature and flavor are pungent, sweet, warm; Return liver, kidney channel.Main effect is kidney invigorating and YANG supporting, wind-damp dispelling.
The pungent warm-dryness syndrome of Herba Epimedii is loose, and the damp of can dispeling the wind, the gas that again can temperature activates yang, promote blood operation, blood bitterly only and muscle soft pulse profit is nourished, therefore treatment women's ovary disease should be used it.
Stigma Croci
Stigma Croci nature and flavor are pungent, warm; GUIXIN, Liver Channel.Main effect is blood circulation promoting and blood stasis dispelling dysmenorrhea.
Stigma Croci is invigorated blood circulation, and is good at and stimulates the menstrual flow, and has the effect of stimulating the menstrual flow of stronger blood circulation promoting and blood stasis dispelling, cures mainly married woman and is retarded by silt and stimulates the menstrual flow, and amenorrhea, through without the settled date etc.
embodiment 1
Thank so-and-so, female, 27 years old, people from Anyang City, in August, 2010,21Dao Wo institute was medical.Marry and within 3 years, have no conceived, by local hospital color ultrasound examination, diagnosis is polycystic ovary syndrome.At local hospital, adopt Western medicine to cure to have no half a year obvious curative effects, after arrive again Beijing hospital admission, doctor advised operative treatment, patient considers the reasons such as operation risk is large, and relapse rate is high, expense height, has abandoned operative treatment.After through the check of our color ultrasound, patient's ovary image: 4.9 * 2.1 centimetres of visible 40 left and right follicles of right ovarian size, larger 0.4 * 0.4 centimetre; 5.5 * 1.6 centimetres of left ovarian sizes, visible 40 left and right follicles, larger 0.4 * 0.4 centimetre, be just diagnosed as polycystic ovary syndrome, again in conjunction with the prestige of the traditional Chinese medical science, hear, ask, palpation is disconnected, patient belongs to the polycystic ovary syndrome that liver,spleen,kidney functional disorder causes.My doctor of institute, in conjunction with patient's s own situation, has outputed conditioning viscera body function to her, the Chinese medicine of main harmonizing the liver and spleen kidney: 12 grams of stir-baked SQUAMA MANITISs, 12 grams of the Cortexs Eucommiae, 13 grams of Semen Cuscutae, 10 grams of Endothelium Corneum Gigeriae Galli, 22 grams of Radix Rehmanniae Preparata, 10 grams of Herba Epimedii, 3 grams of Stigma Crocis.Every day, potion, decocted soup for oral administration, serve on 30 days and checked afterwards.
Within 2010, JIUYUE is checked on the 20th, and the whole health of patient is than well a lot of in the past, and color ultrasound examination intrauterine follicle diminishes gradually, disappears.Side does not change, and allows her serve on two months again.After half a year, follow up a case by regular visits to, patient's private prosecution originally bimestrial medicine not finish off menstruation just normal, just conceived during drug withdrawal one and a half months.By Effect of follow-up visit by telephone repeatedly, there are no the disease of discomfort.
experimental data
Treatment polycystic ovary disease, 8 grams of stir-baked SQUAMA MANITISs, 12 grams of the Cortexs Eucommiae, 12 grams of Semen Cuscutae, 8 grams of Endothelium Corneum Gigeriae Galli, 20 grams of Radix Rehmanniae Preparata, 12 grams of Herba Epimedii, 3 grams of Stigma Crocis, add and subtract with disease, every day, potion, decocted soup for oral administration, and serveing on 30 doses is a course for the treatment of, sick the lighter can be healed two courses for the treatment of, severe one needs to treat 3 courses for the treatment of continuously, treats altogether polycystic ovary 3869 examples, 3733 examples of fully recovering, account for 96.5%, effective 121 examples, account for 3.1%, and only 15 examples are invalid.Responding time is 15-27 days, mostly is about 22 days, generally in 70 days, cures.
Above embodiment is only for illustrating the preferred embodiment of the present invention; but the present invention is not limited to above-mentioned embodiment; in the ken possessing at described field those of ordinary skill; it any modification of doing within the spirit and principles in the present invention, is equal to and substitutes and improvement etc., within all should be encompassed in the technical scheme scope that the present invention asks for protection.
Claims (1)
1. a pharmaceutical composition for the treatment of polycystic ovary syndrome, is characterized in that, is formed: stir-baked SQUAMA MANITIS, the Cortex Eucommiae, Semen Cuscutae, Endothelium Corneum Gigeriae Galli, Radix Rehmanniae Preparata, Herba Epimedii, Stigma Croci by following medicine components proportioning; Described each component according to quality proportioning is: 8 grams of stir-baked SQUAMA MANITISs, 12 grams of the Cortexs Eucommiae, 12 grams of Semen Cuscutae, 8 grams of Endothelium Corneum Gigeriae Galli, 20 grams of Radix Rehmanniae Preparata, 12 grams of Herba Epimedii, 3 grams of Stigma Crocis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210108674.4A CN102600313B (en) | 2012-04-15 | 2012-04-15 | Medicinal composition for treating polycystic ovary syndrome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210108674.4A CN102600313B (en) | 2012-04-15 | 2012-04-15 | Medicinal composition for treating polycystic ovary syndrome |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102600313A CN102600313A (en) | 2012-07-25 |
CN102600313B true CN102600313B (en) | 2014-02-26 |
Family
ID=46518332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210108674.4A Expired - Fee Related CN102600313B (en) | 2012-04-15 | 2012-04-15 | Medicinal composition for treating polycystic ovary syndrome |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102600313B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101049405A (en) * | 2007-05-16 | 2007-10-10 | 北京艺信堂医药研究所 | Preparation of Chinese traditional medicine for treating barrenness caused by obstruction of ovulation |
CN101890081A (en) * | 2009-05-19 | 2010-11-24 | 李鑫 | Formula of Chinese medicament for treating female infertility and processing method of Chinese medicament |
-
2012
- 2012-04-15 CN CN201210108674.4A patent/CN102600313B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101049405A (en) * | 2007-05-16 | 2007-10-10 | 北京艺信堂医药研究所 | Preparation of Chinese traditional medicine for treating barrenness caused by obstruction of ovulation |
CN101890081A (en) * | 2009-05-19 | 2010-11-24 | 李鑫 | Formula of Chinese medicament for treating female infertility and processing method of Chinese medicament |
Non-Patent Citations (2)
Title |
---|
名老中医治疗多囊卵巢综合征临床经验浅析;李淑女等;《中医临床研究》;20120115;第4卷(第1期);75-77 * |
李淑女等.名老中医治疗多囊卵巢综合征临床经验浅析.《中医临床研究》.2012,第4卷(第1期),75-77. |
Also Published As
Publication number | Publication date |
---|---|
CN102600313A (en) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104547750A (en) | Traditional Chinese medicine composition for treating senile osteoporosis | |
CN103877247B (en) | Medicine being used for the treatment of decubital ulcer and preparation method thereof | |
CN101264146A (en) | Externally-applied Chinese herbal medicine for treating muscle and joint disease and preparation thereof | |
CN104027461B (en) | A kind of Chinese medicine composition treating urticaria | |
CN105695273A (en) | Health-care wine | |
CN105079184A (en) | Medicine for treating osteoporosis | |
CN100396321C (en) | Preparation of Chinese traditional medicine for treating hyperosteogeny | |
CN1879838A (en) | A Chinese medicine for treating threatened abortion | |
CN102973677A (en) | Traditional Chinese medicine for treating ovarian cyst | |
CN104688929A (en) | Traditional Chinese medicine for treating liver-kidney deficiency type dysmenorrhea | |
CN101862414B (en) | Chinese medicinal composition for treating impotence | |
CN102600313B (en) | Medicinal composition for treating polycystic ovary syndrome | |
CN102028835B (en) | Chinese medicinal composition for treating fracture | |
CN102247505A (en) | Chinese medical composition for treating sterility of multiparous cow after repeated mating and treatment method of sterility of multiparous cow after repeated mating | |
CN106860717A (en) | It is a kind of to treat infertile medicine | |
CN1089602C (en) | Medicinal composition for treating bone fracture and its preparing process | |
CN103860800A (en) | Pharmaceutical composition for treating osteoporosis | |
CN102078516A (en) | Traditional Chinese medicine for treating bone injury | |
CN102349969A (en) | Traditional Chinese medicinal preparation for preventing sterility due to weak and fewer sperms | |
CN104173995A (en) | Traditional Chinese medicine preparation for treating dysmenorrhea | |
CN105456538A (en) | Drug for treating osteoporosis | |
CN105749077A (en) | Traditional Chinese medicine composition for treating female infertility | |
DONG et al. | Thirty-eight cases of uterine bleeding of spleen deficiency treated with wheat-grain size cone moxibustion and herbal plaster on the umbilicus | |
CN104147389A (en) | Medicine for discharging gallstone | |
CN104306865A (en) | Traditional Chinese medicine preparation for treating threatened abortion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140226 Termination date: 20150415 |
|
EXPY | Termination of patent right or utility model |